Achilles Therapeutics is a bio-pharmaceutical firm that specializes in developing precision T-cell therapies to treat solid tumors. They have two lead products, CHIRON and THETIS, which are currently undergoing Phase I/IIa clinical trials for non-small cell lung cancer and recurrent melanoma respectively. Achilles Therapeutics is also working on developing products to treat other types of cancer, such as breast and bladder cancer.